These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2231596)

  • 1. Synthesis, biological profile, and quantitative structure-activity relationship of a series of novel 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
    Sit SY; Parker RA; Motoc I; Han W; Balasubramanian N; Catt JD; Brown PJ; Harte WE; Thompson MD; Wright JJ
    J Med Chem; 1990 Nov; 33(11):2982-99. PubMed ID: 2231596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective inhibition of cholesterol synthesis in liver versus extrahepatic tissues by HMG-CoA reductase inhibitors.
    Parker RA; Clark RW; Sit SY; Lanier TL; Grosso RA; Wright JJ
    J Lipid Res; 1990 Jul; 31(7):1271-82. PubMed ID: 2401858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A potent, tissue-selective, synthetic inhibitor of HMG-CoA reductase.
    Balasubramanian N; Brown PJ; Catt JD; Han WT; Parker RA; Sit SY; Wright JJ
    J Med Chem; 1989 Sep; 32(9):2038-41. PubMed ID: 2769677
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibitors of cholesterol biosynthesis. 4. trans-6-[2-(substituted-quinolinyl)ethenyl/ethyl]tetrahydro-4-hydroxy-2 H-pyran-2-ones, a novel series of HMG-CoA reductase inhibitors.
    Sliskovic DR; Picard JA; Roark WH; Roth BD; Ferguson E; Krause BR; Newton RS; Sekerke C; Shaw MK
    J Med Chem; 1991 Jan; 34(1):367-73. PubMed ID: 1992138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors of cholesterol biosynthesis. 3. Tetrahydro-4-hydroxy-6-[2-(1H-pyrrol-1-yl)ethyl]-2H-pyran-2-one inhibitors of HMG-CoA reductase. 2. Effects of introducing substituents at positions three and four of the pyrrole nucleus.
    Roth BD; Blankley CJ; Chucholowski AW; Ferguson E; Hoefle ML; Ortwine DF; Newton RS; Sekerke CS; Sliskovic DR; Stratton CD
    J Med Chem; 1991 Jan; 34(1):357-66. PubMed ID: 1992137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy, tissue distribution and biliary excretion of methyl (3R*,5S*)-(E)-3,5-dihydroxy-9,9-diphenyl-6,8-nonadienoate (CP-83101), a hepatoselective inhibitor of HMG-CoA reductase activity in the rat.
    Harwood HJ; Silva M; Chandler CE; Mikolay L; Pellarin LD; Barbacci-Tobin E; Wint LT; McCarthy PA
    Biochem Pharmacol; 1990 Sep; 40(6):1281-93. PubMed ID: 2403382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological activity of new 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) synthase inhibitors: 2-oxetanones with a side chain mimicking the folded structure of 1233A.
    Hashizume H; Ito H; Yamada K; Nagashima H; Kanao M; Tomoda H; Sunazuka T; Kumagai H; Omura S
    Chem Pharm Bull (Tokyo); 1994 Mar; 42(3):512-20. PubMed ID: 7911741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-Hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors. 7. Modification of the hexahydronaphthalene moiety of simvastatin: 5-oxygenated and 5-oxa derivatives.
    Duggan ME; Alberts AW; Bostedor R; Chao YS; Germershausen JI; Gilfillan JL; Halczenko W; Hartman GD; Hunt V; Imagire JS
    J Med Chem; 1991 Aug; 34(8):2489-95. PubMed ID: 1875346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological activity of bile acid-derived HMG-CoA reductase inhibitors. The role of 21-methyl in recognition of HMG-CoA reductase and the ileal bile acid transport system.
    Wess G; Kramer W; Han XB; Bock K; Enhsen A; Glombik H; Baringhaus KH; Böger G; Urmann M; Hoffmann A
    J Med Chem; 1994 Sep; 37(20):3240-6. PubMed ID: 7932551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological activity of new HMG-CoA reductase inhibitors. 2. Derivatives of 7-(1H-pyrrol-3-yl)-substituted-3,5-dihydroxyhept-6(E)-enoic (-heptanoic) acids.
    Jendralla H; Baader E; Bartmann W; Beck G; Bergmann A; Granzer E; von Kerekjarto B; Kesseler K; Krause R; Schubert W
    J Med Chem; 1990 Jan; 33(1):61-70. PubMed ID: 2153213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of rat liver hydroxymethylglutaryl coenzyme A reductase by a new class of noncompetitive inhibitors. Effects of dichloroacetate and related carboxylic acids on enzyme activity.
    Stacpoole PW; Harwood HJ; Varnado CE
    J Clin Invest; 1983 Nov; 72(5):1575-85. PubMed ID: 6630519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of acyl-CoA:cholesterol O-acyltransferase. synthesis and pharmacological activity of (+/-)-2-dodecyl-alpha-phenyl-N-(2,4,6-trimethoxyphenyl)-2H-tetrazole-5- acetamide and structurally related tetrazole amide derivatives.
    O'Brien PM; Sliskovic DR; Picard JA; Lee HT; Purchase CF; Roth BD; White AD; Anderson M; Mueller SB; Bocan T; Bousley R; Hamelehle KL; Homan R; Lee P; Krause BR; Reindel JF; Stanfield RL; Turluck D
    J Med Chem; 1996 Jun; 39(12):2354-66. PubMed ID: 8691430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of some 3-hydroxy-5-aminopentanoic acid derivatives.
    Carganico G; Cangiano G; Cozzi P; Lovisolo PP
    Farmaco Sci; 1987 Apr; 42(4):277-84. PubMed ID: 3595839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-Alkyl-3-hydroxyglutaric acids: a new class of hypocholesterolemic HMG CoA reductase inhibitors. 1.
    Baran JS; Laos I; Langford DD; Miller JE; Jett C; Taite B; Rohrbacher E
    J Med Chem; 1985 May; 28(5):597-601. PubMed ID: 3989819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological activity of new HMG-CoA reductase inhibitors. 3. Lactones of 6-phenoxy-3,5-dihydroxyhexanoic acids.
    Jendralla H; Granzer E; von Kerekjarto B; Krause R; Schacht U; Baader E; Bartmann W; Beck G; Bergmann A; Kesseler K
    J Med Chem; 1991 Oct; 34(10):2962-83. PubMed ID: 1656041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological profile of a novel synthetic inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
    Aoki T; Nishimura H; Nakagawa S; Kojima J; Suzuki H; Tamaki T; Wada Y; Yokoo N; Sato F; Kimata H; Kitahara M; Toyoda K; Sakashita M; Saito Y
    Arzneimittelforschung; 1997 Aug; 47(8):904-9. PubMed ID: 9296275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lovastatin and simvastatin--inhibitors of HMG CoA reductase and cholesterol biosynthesis.
    Alberts AW
    Cardiology; 1990; 77 Suppl 4():14-21. PubMed ID: 2073667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-selective inhibition of cholesterol synthesis in vivo by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.
    Koga T; Shimada Y; Kuroda M; Tsujita Y; Hasegawa K; Yamazaki M
    Biochim Biophys Acta; 1990 Jul; 1045(2):115-20. PubMed ID: 2116173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMG-CoA reductase inhibitors: design, synthesis, and biological activity of tetrahydroindazole-substituted 3,5-dihydroxy-6-heptenoic acid sodium salts.
    Connolly PJ; Westin CD; Loughney DA; Minor LK
    J Med Chem; 1993 Nov; 36(23):3674-85. PubMed ID: 8246237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of early cholesterol biosynthesis in rat liver: effects of sterols, bile acids, lovastatin, and BM 15.766 on 3-hydroxy-3-methylglutaryl coenzyme A synthase and acetoacetyl coenzyme A thiolase activities.
    Honda A; Salen G; Nguyen LB; Xu G; Tint GS; Batta AK; Shefer S
    Hepatology; 1998 Jan; 27(1):154-9. PubMed ID: 9425931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.